U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT06950034) titled 'A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)' on April 09.
Brief Summary: This is a first-in-human, multicenter, open-label, phase 1 study to evaluate the safety, PK, PD and preliminary efficacy of STX-0712 in patients with advanced CMML and AML for whom there are no further treatment options known to confer clinical benefit.
Study Start Date: March 13
Study Type: INTERVENTIONAL
Condition:
Chronic Myelomonocytic Leukemia
Chronic Myelomonocytic Leukemia (CMML)
Chronic Myelomonocytic Leukemia-1
Chronic Myelomonocytic Leukemia-2
Refractory Chronic Myelomonocytic Leukemia
CMML
Acut...